GB202301024D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- GB202301024D0 GB202301024D0 GBGB2301024.2A GB202301024A GB202301024D0 GB 202301024 D0 GB202301024 D0 GB 202301024D0 GB 202301024 A GB202301024 A GB 202301024A GB 202301024 D0 GB202301024 D0 GB 202301024D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2301024.2A GB202301024D0 (en) | 2023-01-24 | 2023-01-24 | Compounds |
PCT/GB2024/050192 WO2024165831A1 (en) | 2023-01-24 | 2024-01-24 | Imidazolidone and succinimide derivatives for use as alpha v beta 3 integrin inhibitors for the treatment of cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2301024.2A GB202301024D0 (en) | 2023-01-24 | 2023-01-24 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202301024D0 true GB202301024D0 (en) | 2023-03-08 |
Family
ID=85383116
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2301024.2A Ceased GB202301024D0 (en) | 2023-01-24 | 2023-01-24 | Compounds |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB202301024D0 (en) |
WO (1) | WO2024165831A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002022615A1 (en) * | 2000-09-14 | 2002-03-21 | Merck & Co., Inc. | Alpha v integrin receptor antagonists |
LT2953948T (en) * | 2013-02-07 | 2018-01-10 | Scifluor Life Sciences, Inc | Fluorinated integrin antagonists |
CN110167934B (en) | 2016-11-08 | 2022-06-10 | 百时美施贵宝公司 | Cyclobutane-and azetidine-containing monocyclic and spiro compounds as alpha V integrin inhibitors |
TW202028179A (en) * | 2018-10-08 | 2020-08-01 | 美商普萊恩醫療公司 | Amino acid compounds and methods of use |
-
2023
- 2023-01-24 GB GBGB2301024.2A patent/GB202301024D0/en not_active Ceased
-
2024
- 2024-01-24 WO PCT/GB2024/050192 patent/WO2024165831A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2024165831A1 (en) | 2024-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB202200735D0 (en) | Compounds | |
GB202208643D0 (en) | Compounds | |
GB202201996D0 (en) | Compounds | |
GB202305212D0 (en) | Compounds | |
GB202303387D0 (en) | Compounds | |
GB202303419D0 (en) | Compounds | |
GB202303230D0 (en) | Compounds | |
GB202302871D0 (en) | Compounds | |
GB202302237D0 (en) | Tryptophan-based compounds | |
GB202302032D0 (en) | Compounds | |
GB202300995D0 (en) | Compounds | |
GB202301012D0 (en) | Compounds | |
GB202301008D0 (en) | Compounds | |
GB202301000D0 (en) | Compounds | |
GB202301024D0 (en) | Compounds | |
GB202300922D0 (en) | Compounds | |
GB202300021D0 (en) | Compounds | |
GB202219706D0 (en) | Compounds | |
GB202219534D0 (en) | Compounds | |
GB202217844D0 (en) | Compounds | |
GB202217330D0 (en) | Compounds | |
GB202216695D0 (en) | Compounds | |
GB202215664D0 (en) | Compounds | |
GB202215534D0 (en) | Compounds | |
GB202214800D0 (en) | Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |